메뉴 건너뛰기




Volumn 100, Issue 10, 2011, Pages 4050-4073

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: Goals, properties of the PhRMA dataset, and comparison with literature datasets

(17)  Poulin, Patrick a   Jones, Hannah M b   Jones, Rhys Do c   Yates, James W T c   Gibson, Christopher R d   Chien, Jenny Y e   Ring, Barbara J e   Adkison, Kimberly K f   He, Handan g   Vuppugalla, Ragini h   Marathe, Punit h   Fischer, Volker i   Dutta, Sandeep i   Sinha, Vikash K j   Björnsson, Thorir k   Lavé, Thierry l   Ku, M Sherry m  


Author keywords

Allometry; Bioavailability; Clearance; Computational ADME; First in human; Oral absorption; PBPK; Pharmacokinetics; PhRMA; Volume of distribution

Indexed keywords

AMPHOLYTE; DRUG;

EID: 80052269425     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22554     Document Type: Article
Times cited : (50)

References (47)
  • 3
    • 80052267194 scopus 로고    scopus 로고
    • Food and Drug Administration (FDA) Guidance for industry. Rockville, Maryland. Available at:
    • Food and Drug Administration (FDA). 2010. S9 non clinical evaluation for anticancer pharmaceuticals. Guidance for industry. Rockville, Maryland. Available at:.
    • (2010) S9 non clinical evaluation for anticancer pharmaceuticals
  • 4
    • 0025360796 scopus 로고
    • Pharmacologically guided phase I clinical trials based upon preclinical drug development
    • Collins JM, Grieshaber CK, Chabner BA. 1990. Pharmacologically guided phase I clinical trials based upon preclinical drug development. J Natl Cancer Inst 82:1321-1326.
    • (1990) J Natl Cancer Inst , vol.82 , pp. 1321-1326
    • Collins, J.M.1    Grieshaber, C.K.2    Chabner, B.A.3
  • 5
    • 0028792083 scopus 로고
    • First-time-in-human dose selection: Allometric thoughts and perspectives
    • Boxenbaum H, DiLea C. 1995. First-time-in-human dose selection: Allometric thoughts and perspectives. J Clin Pharmacol 35:943-956.
    • (1995) J Clin Pharmacol , vol.35 , pp. 943-956
    • Boxenbaum, H.1    DiLea, C.2
  • 6
    • 33747154776 scopus 로고    scopus 로고
    • Prediction of human drug clearance from animal data: Application of the rule of exponent and fu corrected intercept method (FCIM)
    • Mahmood I. 2006. Prediction of human drug clearance from animal data: Application of the rule of exponent and fu corrected intercept method (FCIM). J Pharm Sci 95:1810-1821.
    • (2006) J Pharm Sci , vol.95 , pp. 1810-1821
    • Mahmood, I.1
  • 7
    • 0036379076 scopus 로고    scopus 로고
    • Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches
    • Mahmood I. 2002. Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches. Drug Metab Drug Inter 19:49-64.
    • (2002) Drug Metab Drug Inter , vol.19 , pp. 49-64
    • Mahmood, I.1
  • 8
    • 0029828960 scopus 로고    scopus 로고
    • Interspecies scaling: Predicting clearance of drugs in humans. Three different approaches
    • Mahmood I, Balian JD. 1996. Interspecies scaling: Predicting clearance of drugs in humans. Three different approaches. Xenobiotica 26:887-895.
    • (1996) Xenobiotica , vol.26 , pp. 887-895
    • Mahmood, I.1    Balian, J.D.2
  • 9
    • 0036356378 scopus 로고    scopus 로고
    • Interspecies scaling: Predicting oral clearance in humans
    • Mahmood I. 2002. Interspecies scaling: Predicting oral clearance in humans. Am J Ther 9:35-42.
    • (2002) Am J Ther , vol.9 , pp. 35-42
    • Mahmood, I.1
  • 10
    • 2442680354 scopus 로고    scopus 로고
    • A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance
    • Ward KW, Smith BR. 2004. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance. Drug Metab Dispos 32:603-611.
    • (2004) Drug Metab Dispos , vol.32 , pp. 603-611
    • Ward, K.W.1    Smith, B.R.2
  • 11
    • 34748919740 scopus 로고    scopus 로고
    • Interspecies prediction of human drug clearance based on scaling data from one or two animal species
    • Tang H, Hussain A, Leal M, Mayersohn M, Fluhler E. 2007. Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Drug Metab Dispos 35:1886-1893.
    • (2007) Drug Metab Dispos , vol.35 , pp. 1886-1893
    • Tang, H.1    Hussain, A.2    Leal, M.3    Mayersohn, M.4    Fluhler, E.5
  • 12
    • 23944515735 scopus 로고    scopus 로고
    • A novel method for prediction of human drug clearance by allometric scaling
    • Tang H, Mayersohn M. 2005. A novel method for prediction of human drug clearance by allometric scaling. Drug Metab Dispos 33:1297-1303.
    • (2005) Drug Metab Dispos , vol.33 , pp. 1297-1303
    • Tang, H.1    Mayersohn, M.2
  • 13
    • 0345306618 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: Oral clearance
    • Wajima T, Fukumura K, Yano Y, Oguma T. 2003. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: Oral clearance. J Pharm Sci 92:2427-2440.
    • (2003) J Pharm Sci , vol.92 , pp. 2427-2440
    • Wajima, T.1    Fukumura, K.2    Yano, Y.3    Oguma, T.4
  • 14
    • 0032733974 scopus 로고    scopus 로고
    • Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes
    • Obach RS. 1999. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350-1359.
    • (1999) Drug Metab Dispos , vol.27 , pp. 1350-1359
    • Obach, R.S.1
  • 15
    • 46449114275 scopus 로고    scopus 로고
    • Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds
    • Obach RS, Lombardo F, Waters NJ. 2008. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos 36:1385-1405.
    • (2008) Drug Metab Dispos , vol.36 , pp. 1385-1405
    • Obach, R.S.1    Lombardo, F.2    Waters, N.J.3
  • 18
    • 80052273956 scopus 로고    scopus 로고
    • Prediction of human drug clearance from two species: A comparison of several allometric methods
    • Goteti K, Garner CE, Mahmood I. 2009. Prediction of human drug clearance from two species: A comparison of several allometric methods. J Pharm Sci 10:1-13.
    • (2009) J Pharm Sci , vol.10 , pp. 1-13
    • Goteti, K.1    Garner, C.E.2    Mahmood, I.3
  • 19
    • 33646124969 scopus 로고    scopus 로고
    • A novel strategy for physiologically based predictions of human pharmacokinetics
    • Jones HM, Parrott N, Jorga K, Lave T. 2006. A novel strategy for physiologically based predictions of human pharmacokinetics. Clin Pharmacokinet 45(5):511-542.
    • (2006) Clin Pharmacokinet , vol.45 , Issue.5 , pp. 511-542
    • Jones, H.M.1    Parrott, N.2    Jorga, K.3    Lave, T.4
  • 20
    • 34748925493 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs
    • De Buck SS, Sinha VK, Fenu LA, Nijsen MJ, Mackie CE, Gilissen RA. 2007. Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs. Drug Metab Dispos 35:1766-1780.
    • (2007) Drug Metab Dispos , vol.35 , pp. 1766-1780
    • De, B.S.1    Sinha, V.K.2    Fenu, L.A.3    Nijsen, M.J.4    Mackie, C.E.5    Gilissen, R.A.6
  • 21
    • 34548393250 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics: Evaluation of methods for prediction of volume of distribution
    • Fagerholm U. 2007. Prediction of human pharmacokinetics: Evaluation of methods for prediction of volume of distribution. J Pharm Pharmacol 59:1181-1190.
    • (2007) J Pharm Pharmacol , vol.59 , pp. 1181-1190
    • Fagerholm, U.1
  • 22
    • 34447312263 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics: Evaluation of methods for prediction of hepatic metabolic clearance
    • Fagerholm U. 2007. Prediction of human pharmacokinetics: Evaluation of methods for prediction of hepatic metabolic clearance. J Pharm Pharmacol 59:803-828.
    • (2007) J Pharm Pharmacol , vol.59 , pp. 803-828
    • Fagerholm, U.1
  • 23
    • 34447337731 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics: Gastrointestinal absorption
    • Fagerholm U. 2007. Prediction of human pharmacokinetics: Gastrointestinal absorption. J Pharm Pharmacol 59:905-916.
    • (2007) J Pharm Pharmacol , vol.59 , pp. 905-916
    • Fagerholm, U.1
  • 24
    • 77957344287 scopus 로고    scopus 로고
    • Prediction of human metabolic clearance from in vitro systems: Retrospective analysis and prospective view
    • Halifax D, Foster JA, Houston BJ. 2010. Prediction of human metabolic clearance from in vitro systems: Retrospective analysis and prospective view. Pharm Res 27:2150-2161.
    • (2010) Pharm Res , vol.27 , pp. 2150-2161
    • Halifax, D.1    Foster, J.A.2    Houston, B.J.3
  • 29
    • 71649089269 scopus 로고    scopus 로고
    • Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods
    • Poulin P, Theil FP. 2009. Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods. J Pharm Sci 98:4941-4961.
    • (2009) J Pharm Sci , vol.98 , pp. 4941-4961
    • Poulin, P.1    Theil, F.P.2
  • 30
    • 34347396549 scopus 로고    scopus 로고
    • A unified approach for assessing agreement for continuous and categorical data
    • Lin L, Hedayat AS, Wu W. 2007. A unified approach for assessing agreement for continuous and categorical data. J Biopharm Stat 17:629-652.
    • (2007) J Biopharm Stat , vol.17 , pp. 629-652
    • Lin, L.1    Hedayat, A.S.2    Wu, W.3
  • 31
    • 84975207356 scopus 로고    scopus 로고
    • A note on the concordance correlation coefficient
    • Lin L. 2000. A note on the concordance correlation coefficient. Biometrics 56:324-325.
    • (2000) Biometrics , vol.56 , pp. 324-325
    • Lin, L.1
  • 33
    • 33846176619 scopus 로고    scopus 로고
    • A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan
    • Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. 2006. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharmacol 3:631-643.
    • (2006) Mol Pharmacol , vol.3 , pp. 631-643
    • Takagi, T.1    Ramachandran, C.2    Bermejo, M.3    Yamashita, S.4    Yu, L.X.5    Amidon, G.L.6
  • 36
    • 3843097202 scopus 로고    scopus 로고
    • Classification of orally administered drugs on the World Health Organization model of essential medicines according to the biopharmaceutics classification system
    • Lindenberg M, Kopp S, Dressman JB. 2004. Classification of orally administered drugs on the World Health Organization model of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 58:265-278.
    • (2004) Eur J Pharm Biopharm , vol.58 , pp. 265-278
    • Lindenberg, M.1    Kopp, S.2    Dressman, J.B.3
  • 37
    • 17644380257 scopus 로고    scopus 로고
    • Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
    • Wu CY, Benet LZ. 2005. Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 22:11-23.
    • (2005) Pharm Res , vol.22 , pp. 11-23
    • Wu, C.Y.1    Benet, L.Z.2
  • 38
    • 51249121664 scopus 로고    scopus 로고
    • An oral formulation decision tree based on the biopharmaceutical classification system for first in human clinical trials
    • Ku SM. 2006. An oral formulation decision tree based on the biopharmaceutical classification system for first in human clinical trials. Gattefossé Bull Tech 99:89-92.
    • (2006) Gattefossé Bull Tech , vol.99 , pp. 89-92
    • Ku, S.M.1
  • 39
    • 80052272017 scopus 로고    scopus 로고
    • World Health Organization (WHO) 14th ed. Geneva, Switzerland. Available at:
    • World Health Organization (WHO). 2005. List of essential drugs. 14th ed. Geneva, Switzerland. Available at:.
    • (2005) List of essential drugs
  • 40
    • 0031024171 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • Lipiniski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25.
    • (1997) Adv Drug Deliv Rev , vol.23 , pp. 3-25
    • Lipiniski, C.A.1    Lombardo, F.2    Dominy, B.W.3    Feeney, P.J.4
  • 41
    • 0002041834 scopus 로고    scopus 로고
    • Multivariate pharmaceutical profiling for drug discovery
    • Kerns EH, Di L. 2002. Multivariate pharmaceutical profiling for drug discovery. Curr Top Med Chem 2:87-98.
    • (2002) Curr Top Med Chem , vol.2 , pp. 87-98
    • Kerns, E.H.1    Di, L.2
  • 44
    • 0027155519 scopus 로고
    • Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment
    • Smith DA. 1993. Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment. Eur J Drug Metab Pharmacokinet 18:31-39.
    • (1993) Eur J Drug Metab Pharmacokinet , vol.18 , pp. 31-39
    • Smith, D.A.1
  • 45
    • 16844366148 scopus 로고    scopus 로고
    • Review of UCN-01 development: A lesson in the importance of clinical pharmacology
    • Fuse E, Kuwabara T, Sparreboom A, Sausville EA, Figg WD. 2005. Review of UCN-01 development: A lesson in the importance of clinical pharmacology. J Clin Pharmacol 45:394-403.
    • (2005) J Clin Pharmacol , vol.45 , pp. 394-403
    • Fuse, E.1    Kuwabara, T.2    Sparreboom, A.3    Sausville, E.A.4    Figg, W.D.5
  • 46
    • 70350255269 scopus 로고    scopus 로고
    • Food and Drug Administration (FDA) Guidance for the Industry. Rockville, Maryland. Available at:
    • Food and Drug Administration (FDA). 2008. Safety testing of drug metabolites. Guidance for the Industry. Rockville, Maryland. Available at:.
    • (2008) Safety testing of drug metabolites
  • 47
    • 70350348642 scopus 로고    scopus 로고
    • To scale or not to scale: The principles of dose extrapolation
    • Sharma V, McNeill JH. 2009. To scale or not to scale: The principles of dose extrapolation. Br J Pharmacol 157:907-921.
    • (2009) Br J Pharmacol , vol.157 , pp. 907-921
    • Sharma, V.1    McNeill, J.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.